Skip to main content
LXEO
NASDAQ Life Sciences

Lexeo Acquires Mantle Therapeutics, Adds Strategic Collaborations in Friedreich Ataxia

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$4.18
Mkt Cap
$334.749M
52W Low
$3.99
52W High
$10.99
52W Position info
4.8% above low
Off High info
62% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

LXEO is trading near its 52-week low of $3.99 (4.8% above the low).

Summary

Lexeo Therapeutics is acquiring Mantle Therapeutics for an upfront payment of $8.3M, consisting of $5.3M cash and $3M stock, plus a $1M additional cash payment and up to $12M in milestone payments over 12 years, and announcing multiple new strategic collaborations to expand its leadership in Friedreich Ataxia. Key stockholders holding 76.1% of Mantle shares agreed to vote in favor. The collaborations will evaluate gene therapy sequential dosing following treatment with LX2006. The acquisition and partnerships strengthen Lexeo's pipeline in a rare disease area where it has the SUNRISE-FA 2 pivotal trial for LX2006 underway. The news follows recent FDA RMAT designation for LX2020 and extends the company's cash runway into 2028. Lexeo has a market cap around $335M and is trading near its 52-week low. No other financial terms were disclosed.

Updated with an SEC 8-K filing · What changed

Updates

  1. · SEC 8-K — The merger agreement provides $5.3M cash and $3M stock upfront, plus a $1M additional cash payment and up to $12M in milestone payments over 12 years. Key stockholders holding 76.1% of Mantle shares agreed to vote in favor.

At the time of this announcement, LXEO was trading at $4.18 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $334.7M. The 52-week trading range was $3.99 to $10.99. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

LXEO - Latest Insights

LXEO
Nov 16, 2026, 7:05 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $3.20
Real-time Price: $3.04 info
Change: -$0.160 (-5%) info
Market Cap: $251.677M info
LXEO
Nov 16, 2026, 7:02 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $2.99
Real-time Price: $3.04 info
Change: +$0.050 (+2%) info
Market Cap: $251.677M info
LXEO
Nov 16, 2026, 7:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $2.85
Real-time Price: $3.04 info
Change: +$0.190 (+7%) info
Market Cap: $251.677M info
LXEO
Nov 02, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $3.14
Real-time Price: $3.04 info
Change: -$0.100 (-3%) info
Market Cap: $251.677M info
LXEO
Sep 22, 2026, 7:08 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.84
Real-time Price: $3.04 info
Change: -$0.804 (-21%) info
Market Cap: $251.677M info